Endocyte Loss Narrows Amid Pending Acquisition

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)
WEST LAFAYETTE -

West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is reporting a third quarter net loss of $12.6 million, compared to a net loss of $23.3 million during the same period a year earlier. The biopharmaceutical company is in the midst of a proposed $2.1 billion acquisition by Switzerland-based Novartis AG, which is expected to close in the first half of next year. The deal is considered the largest of its kind ever for an Indiana life sciences company.

Chief Executive Officer Mike Sherman says "the team at Endocyte has always been passionate about developing innovative therapies to help change the treatment landscape for cancer patients, and we look forward to being able to leverage Novartis' global expertise and commitment to help realize this mission."

The company's research and development expenses more than doubled to $8.9 million in the quarter, compared to the third quarter last year. Endocyte expects cash, cash equivalents and investments balance at the end of the year to be greater than $310 million.

You can connect to more about the company's third quarter results by clicking here.

  • Perspectives

    • Unmasking Accounting Data: Moving from Reporting to Being Strategic

      What story do our financial statements tell us this month and year, to date? This was the question that was always directed at us by a former manager.  He believed that financial statements tell the story of how a business is run and the direction it’s going. Most businesses publish their profit and loss statements, and balance sheets every month. These are the standard reports included in most reporting packages. Usually, the management tends to believe...
    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Apartment Building Development Coming to Rushville

      A Knightstown company has announced plans to build four new apartment buildings in a $5.25 million development in Rushville. Villa Buildings will be built by KDC Investments, Inc on West 16th Street in Rushville.

    • The Mystery of Cancer in Firefighters: Two Indiana Researchers Uncover Clues

      There’s a lot of conjecture about cancer in the world of firefighting, but a crescendo of anecdotal—and scientific—evidence is driving two Indiana researchers to search for answers. 

    • BraunAbility Moving Global HQ to Carmel

      A manufacturer of wheelchair vehicles and wheelchair lifts in Pulaski County has announced plans to relocate its global headquarters to Carmel. BraunAbility says it will invest $7.5 million to move its HQ to the Lakeside Green Business Center and construct a new Research & Development and Technology Center. The Indiana Economic Development Corp. says the move will create up to 70 jobs in Hamilton County. The company says the investment will also boost its existing...

    • Indy Eleven Rallies For State Stadium Support

      Indy Eleven leadership, players and fans Thursday rallied at the Statehouse for support of a measure creating a public-private partnership to help fund a $150 million soccer stadium. Lawmakers are considering a measure that would allow the team to work with city leaders for two years on development plans for the venue, which would be funded by developer-backed bonds. In an interview with Inside INdiana Business Reporter Mary-Rachel Redman, team owner Ersal Ozdemir said the...

    • On-Air

      Find out when and where you can watch and listen to our reports.